UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women

BMC cancer, 2022-01, Vol.22 (1), p.18-18, Article 18

2022

Volltextzugriff (PDF)

Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers

Journal of Cancer, 2021-01, Vol.12 (14), p.4372-4378

2021

Volltextzugriff (PDF)

Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal Antibodies

The oncologist (Dayton, Ohio), 2022-06, Vol.27 (6), p.487-492

2022

Volltextzugriff (PDF)

The role of grip strength and short physical performance battery test in predicting chemotherapy-related outcomes in older adults with cancer

Journal of geriatric oncology, 2022-04, Vol.13 (3), p.318-324

2022

Volltextzugriff (PDF)

Role of the vulnerable elders survey-13 screening tool in predicting treatment plan modification for older adults with cancer

Journal of geriatric oncology, 2021-06, Vol.12 (5), p.786-792

2021

Volltextzugriff (PDF)

Abstract P4-10-11: PIK3CA status as a predictor of benefit from drugs targeting the PI3K/AKT/mTOR pathway: A meta-analysis of randomized trials

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P4-P4-10-11

2020

Volltextzugriff (PDF)

FDG-PET Utilizing Deauville Scoring Is Superior to Conventional Imaging for Staging and Response Assessment in Pediatric and Adult Patients with Nodular Lymphocyte Predominant Hodgkin's Lymphoma

Blood, 2017-12, Vol.130, p.1519-1519

2017

Volltextzugriff (PDF)

Optimism bias in the design of phase III randomized control trials (RCTs) evaluating PD-1/PD-L1 targeting monoclonal antibodies (mAbs)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18616-e18616

2021

Volltextzugriff (PDF)

Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population

American journal of human genetics, 2019-06, Vol.104 (6), p.1182-1201

2019

Volltextzugriff (PDF)

Macrocytosis as a predictor of response to capecitabine in solid cancers: A meta-analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e13080-e13080

2020

Volltextzugriff (PDF)

Comparative efficacy, safety, and tolerability of immune checkpoint inhibitors (ICIs) in cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15151-e15151

2020

Volltextzugriff (PDF)

Prognostic value of programmed death-ligand 1 in solid tumors: A meta-analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19121-e19121

2020

Volltextzugriff (PDF)

Predictive role of Vulnerable Elders Survey-13 screen tool for elder cancer patients in final oncology treatment plan

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e24020-e24020

2020

Volltextzugriff (PDF)

Impact of age on outcomes and symptoms in patients with advanced gastroesophageal cancer (GEC)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.193-193

2021

Volltextzugriff (PDF)

Validity of a self-administered G8 screening test for older patients with cancer

Journal of geriatric oncology, 2023-09, Vol.14 (7), p.101553-101553, Article 101553

2023

Volltextzugriff (PDF)

Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population

American journal of human genetics, 2019-10, Vol.105 (4), p.879-879

2019

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women

Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid Cancers

Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal Antibodies

The role of grip strength and short physical performance battery test in predicting chemotherapy-related outcomes in older adults with cancer

Role of the vulnerable elders survey-13 screening tool in predicting treatment plan modification for older adults with cancer

Abstract P4-10-11: PIK3CA status as a predictor of benefit from drugs targeting the PI3K/AKT/mTOR pathway: A meta-analysis of randomized trials

FDG-PET Utilizing Deauville Scoring Is Superior to Conventional Imaging for Staging and Response Assessment in Pediatric and Adult Patients with Nodular Lymphocyte Predominant Hodgkin's Lymphoma

Optimism bias in the design of phase III randomized control trials (RCTs) evaluating PD-1/PD-L1 targeting monoclonal antibodies (mAbs)

Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population

Prenatal exome sequencing and chromosomal microarray analysis in fetal structural anomalies in a highly consanguineous population reveals a propensity of ciliopathy genes causing multisystem phenotypes

Macrocytosis as a predictor of response to capecitabine in solid cancers: A meta-analysis

Comparative efficacy, safety, and tolerability of immune checkpoint inhibitors (ICIs) in cancer

Prognostic value of programmed death-ligand 1 in solid tumors: A meta-analysis

Predictive role of Vulnerable Elders Survey-13 screen tool for elder cancer patients in final oncology treatment plan

Impact of age on outcomes and symptoms in patients with advanced gastroesophageal cancer (GEC)

Validity of a self-administered G8 screening test for older patients with cancer

Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population

Suchergebnisse filtern